Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2013, Article ID 489618, 3 pages
http://dx.doi.org/10.1155/2013/489618
Case Report

Successful Treatment of Localized Pemphigus Foliaceus with Topical Pimecrolimus

11st Department of Dermatology and Venereology, “A. Sygros” Hospital for Skin and Venereal Diseases, University of Athens School of Medicine, 5 Dragoumi Street, 16121 Athens, Greece
2Histopathology Department, “A. Sygros” Hospital for Skin and Venereal Diseases, 5 Dragoumi Street, 16121 Athens, Greece

Received 24 June 2013; Accepted 17 August 2013

Academic Editors: T. Berger and M. Ramos-e-Silva

Copyright © 2013 G. Tyros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Dumas, J. C. Roujeau, P. Wolkenstein, J. Revuz, and A. Cosnes, “The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid,” British Journal of Dermatology, vol. 140, no. 6, pp. 1127–1129, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Danopoulou, P. Stavropoulos, A. Stratigos et al., “Pemphigus vegetans confined to the scalp,” International Journal of Dermatology, vol. 45, no. 8, pp. 1008–1009, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kishibe, M. Kinouchi, A. Ishida-Yamamoto, K. Koike, and H. Iizuka, “Pemphigus foliaceus localized to the nose,” Clinical and Experimental Dermatology, vol. 28, no. 5, pp. 560–562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Hertl, R. Eming, and C. Veldman, “T cell control in autoimmune bullous skin disorders,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1159–1166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. van Kooten and J. Banchereau, “CD40-CD40 ligand,” Journal of Leukocyte Biology, vol. 67, no. 1, pp. 2–17, 2000. View at Google Scholar · View at Scopus
  6. A. K. Gupta and M. Chow, “Pimecrolimus: a review,” Journal of the European Academy of Dermatology and Venereology, vol. 17, no. 5, pp. 493–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Panhans-Groß, N. Novak, S. Kraft, and T. Bieber, “Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506),” Journal of Allergy and Clinical Immunology, vol. 107, no. 2, pp. 345–352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Feliciani, P. Toto, P. Amerio et al., “In vitro and in vivo expression of interleukin-1α and tumor necrosis factor-α mRNA in pemphigus vulgaris: Interleukin-1α and tumor necrosis factor-α are involved in acantholysis,” Journal of Investigative Dermatology, vol. 114, no. 1, pp. 71–77, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Gach and A. Ilchyshyn, “Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris,” Clinical and Experimental Dermatology, vol. 29, no. 3, pp. 271–272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Termeer, K. Technau, M. Augustin, and J. C. Simon, “Topical tacrolimus (protopic) for the treatment of a localized pemphigus foliaceus,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 5, pp. 636–637, 2004. View at Publisher · View at Google Scholar · View at Scopus